The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy.

To determine whether fatal family history (FFH) or mode of inheritance in prostate cancer (PCa) has an impact on long-term outcomes following radical prostatectomy (RP).

1076 PCa patients after RP with at least one deceased first-degree relative with PCa were included and stratified by FFH (four subgroups: fraternal, paternal, multiple, and none) and by mode of inheritance (two subgroups: male to male, non-male to male). We compared clinicopathological characteristics between subgroups with Fisher's exact or Chi-square tests. Biochemical recurrence-free survival (BRFS) and cancer-specific survival (CSS) were analyzed using the method of Kaplan and Meier. Simple and multiple Cox regression with backward elimination were performed to select prognostic factors for BRFS and CSS.

Median age at surgery was 63.3 (range 35.9-79.4) years. The overall Kaplan-Meier estimated BRFS rate at 10 and 15 years was 65.6% and 57.0%, respectively. The overall Kaplan-Meier estimated CSS rate at 10 and 15 years was 98.1% and 95.7%, respectively. Neither FFH nor mode of inheritance were factors associated with worse BRFS. However, in multiple Cox regression, paternal FFH was an important prognostic factor for a better CSS (HR 0.19, CI 0.05-0.71, p = 0.014) compared to non-FFH.

FFH and mode of inheritance do not seem to be prognostic factors of worse long-term outcomes following RP. Rather, a paternal FFH was associated with a better CSS; however, the reasons remain unclear. Nevertheless, patients after RP and FFH could be reassured that their own PCa diagnosis is not associated with a worse long-term outcome.

World journal of urology. 2020 Mar 11 [Epub ahead of print]

Valentin H Meissner, Jamila G H Strüh, Martina Kron, Lea A Liesenfeld, Stephanie Kranz, Jürgen E Gschwend, Kathleen Herkommer

Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Urology, Munich, Germany., Institute of Epidemiology and Medical Biometrics, University of Ulm, Ulm, Germany., Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Urology, Munich, Germany. .